Abstract
The aim of this study was to evaluate outcome in children with juvenile dermatomyositis (JDMS) at a tertiary care center in North India and have a long term follow-up. Medical records of children with JDMS managed at a tertiary care hospital were reviewed during a 13-year period to determine (1) interval between onset of symptoms and diagnosis, (2) treatment modalities used and (3) long term functional outcome. Thirty three patients diagnosed with JDMS met the inclusion criteria. Mean age at diagnosis was 8.7 ± 3.3 years. Mean duration of disease prior to treatment was 1.18 years (range 1 months–5 years). The total follow-up period was 136.7 patient-years. Immunosuppressive therapy was given in 31/33 and a distinct monocyclic course was seen in 72.7% cases. Lipodystrophy was seen in 10/33 (30.3%), calcinosis in 7/33 (27.3%), cutaneous ulcers in 6/33 (18.2%), dysphagia in 5/33 (15.2%), and contractures in 4/33 (12.1%) cases. A steady and sustained response was seen in patients who had received “adequate” doses of steroids at the time of initiation of treatment. Methotrexate, hydroxychloroquine, azathioprine and intravenous immunoglobulin were used in patients with poor response to corticotherapy. There were two deaths in our series. Stepwise, aggressive treatment directed at achieving rapid and complete control of muscle inflammation is highly successful in minimizing the long-range sequelae of JDMS. Our patients seem to have a different clinical profile on follow-up as compared to series published from the West.
Similar content being viewed by others
References
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344–407
Cassidy JT, Petty RE (2001) Juvenile dermatomyositis. In Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology. 4 ed. Saunders, Philadelphia, pp 465–504
Medsger TA Jr, Oddis CV (1995) Classification and diagnostic criteria for polymyositis and dermatomyositis. J Rheumatol 22:581–585
Peloro TM, Miller OF, Hahn TF, Newman ED (2001) Juvenile dermatomyositis: a retrospective review of a 30-year experience. J Am Acad Dermatol 45:28–34
Ito S, Miyamae T, Imagawa T, Katakura S, Mori M, Tomono J et al (1998) Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis. Ryumachi 38:785–792
Pachman LM (1990) Juvenile dermatomyositis: a clinical overview. Pediatr Rev 12:117–125
Norins AL (1989) Juvenile dermatomyositis. Med Clin North Am 73:1193–1209
Sallum AM, Kiss MH, Sachetti S, Resende MB, Moutinho KC, Carvalho Mde S, Silva CA, Marie SK (2002) Juvenile dermatomyositis. Arq Neuro-Psiquiatr 60:889–899
Callen JP (1994) Relationship of cancer to inflammatory muscle disease: dermatomyositis, polymyositis and inclusion body myositis. Rheum Dis Clin N Am 20:943–953
Rider L (1995) Childhood myositis: newly recognized diversity. Ann Intern Med 122:715–724
Shehata R, al-Mayouf S, al-Dalaan A, al- Mazaid A, al-Balaa S, Bahabri S (1999) Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin Exp Rheumatol 17:115–118
Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P et al (2000) Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 43:541–549
Hiketa T, Matsumoto Y, Ohashi M, Sasaki R (1992) Juvenile dermatomyositis: a statistical study of 114 patients with dermatomyositis. J Dermatol 19:470–476
Singh S, Kumar L, Ravi Shankar K (1997) Juvenile dermatomyositis in north India. Indian Pediatr 34:193–198
Chowdhary V, Wakhlu A, Agarwal A, Misra R (2002) Outcome in Juvenile Dermatomyositis. Indian Pediatr 39:931–935
Miller JJ (1973) Late progression in dermatomyositis in childhood. J Pediatr 83:543–548
Sullivan DB, Cassidy JT, Petty RE (1977) Dermatomyositis in pediatric patient. Arthritis Rheum 20:327–331
Al-Mayouf S, Al-Mazyed A, Bahabri S (2000) Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate. Clin Rheum 19:138–141
Bitnum S, Daeschner CW Jr, Travis LB, Dodge WF, Hopps HC (1964) Dermatomyositis. J Pediatr 64:101–131
Yoshioka M, Okuno T, Mikawa H (1985) Prognosis and treatment of polymiositis with particular reference to steroid patients. Arch Dis Child 60:236–244
Spencer CH, Hanson V, Singsen BH, Bernstein BH, Kornreich HK, King KK (1984) Course of treated juvenile dermatomyositis. J Pediatr 105:399–408
Ramanan AV, Feldman BM (2002) Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 28:833–857
Bowyer SL, Blane CE, Sullivan DB, Cassidy JT (1983) Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 103:882–888
Huemer C, Kitson H, Malleson PN, Sanderson S, Huemer M, Cabral DA, et al (2001) Lipodystrophy in patients with juvenile dermatomyositis–evaluation of clinical and metabolic abnormalities. J Rheumatol 28:610–615
Quecedo E, Febrer I, Serrano G, Martinez-Aparicio A, Aliaga A (1996) Partial lipodystrophy associated with juvenile dermatomyositis: report of two cases. Pediatr Dermatol 13:477–482
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, S., Bansal, A. Twelve years experience of juvenile dermatomyositis in North India. Rheumatol Int 26, 510–515 (2006). https://doi.org/10.1007/s00296-005-0030-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-005-0030-2